Dr. Lledó provides strategic counsel and direction to internal and external programs and teams, regionally and globally, for all aspects of the clinical research work and all phases of studies in the neuroscience therapeutic area. He is also the scientific and medical lead at PPD’s Movement Disorders (MD) and at the Multiple Sclerosis (MS) Pillar teams. Based in Barcelona, Dr. Lledó joined PPD in 2017, with more than 22 years of experience with global medical leadership roles in big pharma and as a CMO of a UCL academic spin-off company in London. Dr. Lledó clinical and research focus are in the areas of MD (Parkinson’s disease, Tauopathies, Huntington’s Disease, RLS, etc.) and other neurodegenerative disease. He has also significant experience in multiple sclerosis, pain, and peripheral neuropathies. Dr. Lledó has kept doing part-time clinical practice, as a neurologist, throughout all his pharmaceutical career.
.svg)
